Advertisement

Radiation Therapy with Protons and Heavy Ions

  • Oliver Jäkel

Abstract

The first proton therapy patient was treated in Berkeley at the Lawrence Berkeley Laboratories (LBL) in 1954 and proton therapy celebrates its 60th birthday in 2014 [10]. It is, however, only in the last decade that the number of patients that received proton therapy in dedicated clinical centers is increasing more rapidly. The PTCOG website currently lists 42 proton therapy centers in operation as of August 2014 and 24 new centers currently under construction (see www.ptcog.ch). Heavier ions have also been used first for cancer treatment at LBL in 1957, starting with helium ion treatments and in 1977 with the heavier ions carbon, silicon, neon, and argon [10]. Inspired from the Berkeley experience, the first clinical ion facility in Chiba, Japan, used solely carbon ions for radiotherapy and celebrates its 20th birthday in 2014. Overall 8 facilities worldwide offer carbon treatments, 4 new facilities are under construction (PTCOG lists 3, but an additional facility exists in Marburg), and several projects are in preparation (Japan, Malaysia, Taiwan, Saudi Arabia). It is expected that also carbon ion therapy will be of increasing importance in the future. In this contribution the differences between protons and heavier ions arising from physical and biological characteristics are highlighted and their implications for therapy planning are discussed. The clinical status of carbon ion therapy is summarized and some possible future developments are outlined.

Keywords

Proton Therapy Biological Effective Dose Lawrence Berkeley Laboratory Depth Dose Curve Depth Dose Distribution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bassler N, Toftegaard J, Lühr A, et al. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol. 2014;53(1):25–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Bassler N, Jäkel O, Søndergaard CS, et al. Dose- and LET-painting with particle therapy. Acta Oncol. 2010;49(7):1170–6. Erratum in Acta Oncol. 2013 52(2):458.CrossRefPubMedGoogle Scholar
  3. 3.
    Cabal G, Jäkel O. Towards a novel approach for PTV definition in particle therapy. Radiother Oncol. 2013;107(2):227–33.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen GT, Singh RP, Castro JR, et al. Treatment planning for heavy ion radiotherapy. Int J Radiat Oncol Biol Phys. 1979;5(10):1809–19.CrossRefPubMedGoogle Scholar
  5. 5.
    Ellerbrock M, Jäkel O, Krämer M, et al. Clinical implementation of intensity modulated heavy ion therapy. Radiother Oncol. 2007;84:129.Google Scholar
  6. 6.
    Elsässer T, Scholz M. Improvement of the local effect model (LEM) – implications of clustered DNA damage. Radiat Prot Dosimetry. 2006;122:475–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Elsässer T, Scholz M. Cluster effects within the local effect model. Radiat Res. 2007;167:319–29.CrossRefPubMedGoogle Scholar
  8. 8.
    Friedrich T, Scholz U, Durante M, et al. RBE of ion beams in hypofractionated radiotherapy (SBRT). Phys Med. 2014;30:588–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Furusawa Y, Fukutsu K, Aoki M, et al. Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams. Radiat Res. 2000;154(5):485–96.CrossRefPubMedGoogle Scholar
  10. 10.
    Giap H, Giap B. Historical perspective and evolution of charged particle therapy. Transl Cancer Res. 2012;1(3):27–136.Google Scholar
  11. 11.
    Haberer T, Debus J, Eickhoff H, et al. The Heidelberg Ion Therapy Center. Radiother Oncol. 2004;73 Suppl 2:S186–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Hawkins RB. A microdosimetric – kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications. Int J Radiat Biol. 1996;69:739–95.CrossRefPubMedGoogle Scholar
  13. 13.
    Hawkins RB. A microdosmimetric – kinetic model for the effect of non-Poisson distribution of lethal lesions on the variation of RBE with LET. Radiat Res. 2003;160:61–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Inaniwa T, Furukawa T, Tomitani T, et al. Optimization for fast-scanning irradiation in particle therapy. Med Phys. 2007;34:3302–11.CrossRefPubMedGoogle Scholar
  15. 15.
    Inaniwa T, et al. Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model. Phys Med Biol. 2010;55:6721–37.CrossRefPubMedGoogle Scholar
  16. 16.
    International Commission on Radiation Units and Measurements. Stopping of ions heavier than Helium (Report 73). J ICRU 5. 2005.Google Scholar
  17. 17.
    Jäkel O, Krämer M, Karger CP, et al. Treatment planning for heavy ion radiotherapy: clinical implementation and application. Phys Med Biol. 2001;46:1101–16.CrossRefPubMedGoogle Scholar
  18. 18.
    Jäkel O, Schulz-Ertner D, Debus J. Specifying carbon ion doses for radiotherapy: the Heidelberg approach. J Radiat Res. 2007;48:A87–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Jäkel O. The relative biological effectiveness of proton and ion beams. Z Med Phys. 2008;18(4):276–85.CrossRefPubMedGoogle Scholar
  20. 20.
    Jensen AD, Krauss J, Potthoff K, et al. Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx – TPF-C-HIT. BMC Cancer. 2011;11:182.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:201–10.CrossRefPubMedGoogle Scholar
  22. 22.
    Krämer M, Jäkel O, Haberer T, et al. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol. 2000;45:3299–317.CrossRefPubMedGoogle Scholar
  23. 23.
    Loeffler JS, Durante M. Charged particle therapy – optimization, challenges and future directions. Nat Rev Clin Oncol. 2013;10(7):411–24.CrossRefPubMedGoogle Scholar
  24. 24.
    Mairani A, Brons S, Cerutti F, et al. The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy. Phys Med Biol. 2010;55:4273–89.CrossRefPubMedGoogle Scholar
  25. 25.
    Furukawa T, Inaniwa T, Sato S, et al. Performance of the NIRS fast scanning system for heavy-ion radiotherapy. Med Phys. 2010;37(11):5672–82.CrossRefPubMedGoogle Scholar
  26. 26.
    Parodi K, Mairani A, Brons S. Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility. Phys Med Biol. 2012;57(12):3759–84.CrossRefPubMedGoogle Scholar
  27. 27.
    Raju MR. Heavy particle radiotherapy. New York: Academic Press; 1980.Google Scholar
  28. 28.
    Sato T, Watanabe R, Sihver L, et al. Applications of the microdosimetric function implemented in the macroscopic particle transport simulation code PHITS. Int J Radiat Biol. 2012;88(1–2):143–50.CrossRefPubMedGoogle Scholar
  29. 29.
    Schardt D, et al. Heavy-ion tumor therapy: physical and radiobiological benefits. Rev Mod Physics. 2010;83:382–425.Google Scholar
  30. 30.
    Scholz M, Kraft G. Calculation of heavy ion inactivation probabilities based on track structure, x-ray sensitivity and target size. Radiat Prot Dosim. 1994;52:29–33.Google Scholar
  31. 31.
    Scholz M, Kraft G. Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res. 1996;18:5–14.CrossRefPubMedGoogle Scholar
  32. 32.
    Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer. 2005;104:338–44.CrossRefPubMedGoogle Scholar
  33. 33.
    Sørensen BS, Overgaard J, Bassler N. In vitro RBE-LET dependence for multiple particle types. Acta Oncol. 2011;50(6):757–62.CrossRefPubMedGoogle Scholar
  34. 34.
    Uhl M, Mattke M, Welzel T, et al. Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer. 2014;120(21):3410–7.Google Scholar
  35. 35.
    Uhl M, Mattke M, Welzel T, et al. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results. Cancer. 2014;120(10):1579–85.CrossRefPubMedGoogle Scholar
  36. 36.
    Weber U, Kraft G. Comparison of carbon ions versus protons. Cancer J. 2009;15:325–32.Google Scholar
  37. 37.
    Highland VL. Some practical remarks on multiple scattering. Nuclear Instruments and Methods 1975;129:497–499. Erratum in Nuclear Instruments and Methods 1979;161:171.Google Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of Medical PhysicsGerman Cancer Research CenterHeidelbergGermany
  2. 2.Heidelberg Ion Beam Therapy CenterUniversity Hospital HeidelbergHeidelbergGermany

Personalised recommendations